NM_000719.7:c.1609A>G
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PS3PM2PP3_ModeratePP5_Very_Strong
The NM_000719.7(CACNA1C):c.1609A>G(p.Asn537Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 14/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000741588: Structural modeling performed in house at Ambry Genetics suggests that the p.N537 amino acid is essential for Cav1.2 function as a voltage-dependent calcium channel. The p.N537D alteration may affect the gating of the Cav1.2 channel and transform the channel into a proton channel (Ramsey, 2010" and additional evidence is available in ClinVar. Synonymous variant affecting the same amino acid position (i.e. N537N) has been classified as Likely benign.
Frequency
Consequence
NM_000719.7 missense
Scores
Clinical Significance
Conservation
Publications
- Timothy syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Orphanet
- neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizuresInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- long QT syndromeInheritance: AD Classification: MODERATE Submitted by: ClinGen
- long QT syndrome 8Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- Brugada syndromeInheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: ClinGen, Orphanet
- Brugada syndrome 3Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- short QT syndromeInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000719.7. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNA1C | MANE Select | c.1609A>G | p.Asn537Asp | missense | Exon 12 of 47 | NP_000710.5 | |||
| CACNA1C | MANE Plus Clinical | c.1609A>G | p.Asn537Asp | missense | Exon 12 of 47 | NP_001161095.1 | Q13936-37 | ||
| CACNA1C | c.1609A>G | p.Asn537Asp | missense | Exon 12 of 50 | NP_955630.3 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNA1C | TSL:5 MANE Plus Clinical | c.1609A>G | p.Asn537Asp | missense | Exon 12 of 47 | ENSP00000382512.1 | Q13936-37 | ||
| CACNA1C | TSL:1 MANE Select | c.1609A>G | p.Asn537Asp | missense | Exon 12 of 47 | ENSP00000382563.1 | Q13936-12 | ||
| CACNA1C | c.1699A>G | p.Asn567Asp | missense | Exon 12 of 50 | ENSP00000507184.1 | A0A804HIR0 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at